COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03563599
Brief Title: A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

First Submitted : June 9, 2018
First Submitted that Met QC Criteria : June 9, 2018
First Posted : June 20, 2018

Last Update Submitted that Met QC Criteria : September 9, 2019
Last Update Posted : September 10, 2019